Table 1.
Demographic and baseline characteristics of the participants.
| Feature | BBIBP-CorV | PastoCovac Plus | PastoCovac | P-value |
|---|---|---|---|---|
| Population | (n = 74) | (n = 72) | (n = 68) | |
| Female | 37 (50.0%) | 35 (48.6%) | 34 (50.0%) | 0.982b |
| Male | 37 (50.0%) | 37 (51.4%) | 34 (50.0%) | |
| Age | ||||
| Mean (SD) | 43.0* (14.6) | 41.9 (12.8) | 41.3 (13.8) | 0.775a |
| ≤ 50 | 49 (66.2%) | 53 (73.6%) | 48 (70.6%) | 0.618b |
| > 50 | 25 (33.8%) | 19 (26.4%) | 20 (29.4%) | |
| COVID history | ||||
| No | 60 (81.1%) | 63 (87.5%) | 55 (80.9%) | 0.484b |
| Yes | 14 (18.9%) | 9 (12.5%) | 13 (19.1%) | |
| Underlying disease | ||||
| No | 62 (83.8%) | 65 (90.3%) | 62 (91.2%) | 0.320b |
| Yes | 12 (16.2%) | 7 (9.7%) | 6 (8.8%) | |
SD standard deviation.
aOne-way ANOVA test, bChi-square test.
*A P value > 0.05 was considered significant.